The Coler Lab at Seattle Children’s Research Institute is using their expertise to support the clinical trial of an experimental coronavirus vaccine funded by National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health. The trial is being conducted at the Kaiser Permanente Washington Health Research Institute in Seattle, part of NIAID’s Infectious Diseases Clinical Research Consortium.
By Leila Gray / UW Medicine
“Current criteria using head size to diagnose Zika-related brain injury fail to capture more subtle brain damage that can lead to significant learning problems and mental health disorders later in life,” said Dr. Kristina Adams Waldorf, Professor Global Health and Obstetrics and Gynecology in the University of Washington's Schools of Public Health and Medicine, who specializes in maternal and fetal infections. “We are diagnosing only the tip of the iceberg.”
Teaching Children with Cerebral Palsy to Walk: UW Exoskeleton Project Wins $30,000 to Develop New Technology
Imagine a therapeutic device that children with cerebral palsy could wear at home to strengthen their legs and increase their mobility, eventually allowing them to walk without assistance. Now imagine the device was low-tech and affordable, making it accessible to children around the globe who have limited or no access to expensive therapies that require robotics, supervision by a trained clinician, or invasive surgeries.
By Amiti Addrisi
It's a $1 cup designed to properly feed high-risk babies in under-developed regions of the world.
But don't let the simplicity of the word cup fool you. The design, development, and implementation of the Nifty Cup is the culmination of years of work and partnership with Seattle Children's hospital, the University of Washington and global health organization PATH.